glp 1 bipolar disorder Glucagon-like peptide-1 medicines in neurological and psychiatric disorders: Cell Reports Medicine tirzepatide and bipolar Is (dual

Phase Titration Dose 75 mg Frequency 1-3x weekly Notes Increase by ~25 mg if assessment phase is well tolerated

GLP-1 receptor agonists reduce appetite by mimicking incretin hormones, which can lead to inadequate protein consumption during weight loss

doi: 10.1016/j.tifs.2007.01.007 218

Disease Modification Potential While GLP-1 medications dont cure diabetes, they may modify disease trajectory: Preserved beta cell function: Some evidence suggests GLP-1 medications may help preserve pancreatic beta cells, potentially slowing disease progression

Monitoring and Adjusting Nootropic Use Monitoring and adjusting nootropic use is crucial to ensure safety and effectiveness, as well as to minimize potential side effects